超声引导穿刺硬化术联合地诺孕素治疗卵巢子宫内膜异位囊肿的疗效

doi:10.6040/j.issn.1671-7554.0.2023.0136

摘要/Abstract

摘要： 目的分析超声引导穿刺硬化术联合地诺孕素治疗卵巢子宫内膜异位囊肿(OEM)1年内的临床疗效,及该治疗方案对卵巢储备功能的影响。方法回顾性分析2019年6月至 2020年12月于北京大学深圳医院超声介入中心及妇产中心行超声引导穿刺抽液硬化术后联合地诺孕素管理的20例未婚育龄期OEM患者,通过比较其治疗期间囊肿直径变化、抗苗勒氏管激素(AMH)、血清肿瘤标志物CA-125/CA-199以及视觉模拟评分(VAS)等参数变化,采用配对t检验及秩和检验分析该治疗方案对育龄期OEM的疗效及其对卵巢储备功能的影响,并记录服用地诺孕素过程中发生的不良反应。结果经超声穿刺抽液硬化术联合地诺孕素治疗后的OEM患者,其OEM直径、血清CA-125/CA-199浓度以及痛经VAS评分均呈下降趋势,且与治疗前比较差异均有统计学意义(P<0.01);而卵巢储备功能指标血清AMH水平不受治疗的影响,与治疗前水平比较差异无统计学意义(P>0.01)。此外,不规则阴道出血是地诺孕素长期管理期间最常见的并发症,少数可出现轻度体质量增加、脱发和痤疮等高雄激素等表现。随访过程中均未见药物对肝肾功能、凝血功能、乳腺等不良影响。结论超声引导穿刺抽液硬化术联合地诺孕素治疗OEM可有效缩小囊肿的直径,同时可明显改善患者痛经症状,降低血清CA-125/CA-199数值,对卵巢储备功能影响小。地诺孕素药物治疗不良反应小,可作为超声引导穿刺硬化术治疗OEM的长期管理药物。

关键词: 超声穿刺硬化术, 地诺孕素, 卵巢子宫内膜囊肿, 疗效, 卵巢储备功能

Abstract: Objective To analyze the one-year clinical efficacy of ultrasound-guided puncture sclerotherapy combined with dienogest in the treatment of ovarian endometriotic cyst(OEM)and to explore the impacts on the ovarian reserve function. Methods Clinical data of 20 unmarried OEM patients of childbearing age who underwent ultrasound-guided puncture sclerotherapy combined with dienogest during Jun. 2019 and Dec. 2020 were retrospectively analyzed. The changes in cyst diameter, anti Mullerian hormone(AMH), serum tumor markers CA-125/CA-199 and visual analog scale(VAS)were analyzed. The efficacy and effects on the ovarian reserve function were evaluated with paired t-tests and rank sum tests. Adverse reactions of dienogest were recorded. Results After treatment, the OEM diameter, serum CA-125/CA-199 concentrations and dysmenorrhea VAS score were significantly reduced(P<0.01), while serum AMH level remained unchanged(P>0.01). Irregular vaginal bleeding was the most common complication during long-term dienogest use. A few patients presented with mild weight gain, hair loss, and acnes. No adverse effects on liver and kidney function, coagulation function and mammary gland were observed during follow-up. Conclusion Ultrasound-guided puncture sclerotherapy combined with dienogest can effectively reduce the diameter of cysts in OEM patients, alleviate the menstrual pain and lower serum CA-125/CA-199 levels, with minimal impacts on ovarian reserve function. Dienogest has minimal adverse reactions and can be used for a long-term in the treatment of OEM.

Key words: Ultrasound puncture sclerosis, Dienogest, Ovarian endometrial cyst, Efficacy, Ovarian reserve function

中图分类号:

R711.71

吴磊丽,蔡华丽,孙德胜,魏蔚霞. 超声引导穿刺硬化术联合地诺孕素治疗卵巢子宫内膜异位囊肿的疗效[J]. 山东大学学报 (医学版), 2023, 61(6): 65-69.

WU Leili, CAI Huali, SUN Desheng, WEI Weixia. Effects of ultrasound-guided puncture sclerotherapy combined with dienogest in the treatment of ovarian endometriosis cyst[J]. Journal of Shandong University (Health Sciences), 2023, 61(6): 65-69.

参考文献

[1] Warzecha D, Szymusik I, Wielgos M, et al. The impact of endometriosis on the quality of life and the incidence of depression-a cohort study [J]. Int J Environ Res Public Health, 2020, 17(10): 3641. doi: 10.3390/ijerph17103641.
[2] 中国医师协会妇产科医师分会, 中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症诊治指南(第3版)[J]. 中华妇产科杂志, 2021, 56(12): 812-824.
[3] Becker CM, Bokor A, Heikinheimo O, et al. Eshre guideline: endometriosis [J]. Hum Reprod Open, 2022, 2022(2): hoac9. doi: 10.1093/hropen/hoac009.
[4] Ghiasi M, Kulkarni MT, Missmer SA. Is endometriosis more common and more severe than it was 30 years Ago? [J]. J Minim Invasive Gynecol, 2020, 27(2): 452-461.
[5] Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis [J]. Endocr Rev, 2019, 40(4): 1048-1079.
[6] Kasapoglu I, Ata B, Uyaniklar O, et al. Endometrioma-related reduction in ovarian reserve(error): a prospective longitudinal study [J]. Fertil Steril, 2018, 110(1): 122-127.
[7] Kitajima M, Defrere S, Dolmans MM, et al. Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis [J]. Fertil Steril, 2011, 96(3): 685-691.
[8] Alborzi S, Zahiri SZ, Askari E, et al. The success of various endometrioma treatments in infertility: a systematic review and meta-analysis of prospective studies [J]. Reprod Med Biol, 2019, 18(4): 312-322.
[9] Singh SS, Suen MW. Surgery for endometriosis: beyond medical therapies [J]. Fertil Steril, 2017, 107(3): 549-554.
[10] 王丹凤, 杨君, 卢深涛. 腹腔镜卵巢子宫内膜异位囊肿剥除术对卵巢储备功能和生育影响的研究进展[J]. 安徽医药, 2023, 27(2): 226-229. WANG Danfeng, YANG Jun, LU Shentao. Research progress on the effect of laparoscopic ovarian endometriosis cystectomy on ovarian reserve function and fertility [J]. Anhui Medical and Pharmaceutical Journal, 2023, 27(2): 226-229.
[11] Ghasemi TH, Tavakoli R, Hashemi M, et al. Ethanol sclerotherapy versus laparoscopic surgery in management of ovarian endometrioma; a randomized clinical trial [J]. Arch Acad Emerg Med, 2022, 10(1): e55. doi: 10.22037/aaem.v10i1.1636.
[12] Nasab S, Bedrick BS, Christianson MS. Ethanol sclerotherapy for endometriomas: ready for prime time? [J]. Fertil Steril, 2021, 115(1): 100-101.
[13] 徐辉雄, 王文平, 胡兵, 等. 卵巢子宫内膜异位囊肿超声引导穿刺硬化治疗专家共识[J]. 中华超声影像学杂志, 2020, 29(12): 1013-1024. XU Huixiong, WANG Wenping, HU Bing. Expert consensus on ultrasound-guided puncture sclerotherapy for ovarian endometriosis cyst [J]. Chinese Journal of Ultrasonography, 2020, 29(12): 1013-1024.
[14] 焦瑞爽, 王国仙, 王品. 超声引导下穿刺介入治疗卵巢囊肿对患者卵巢功能、疗效的影响评价[J]. 影像研究与医学应用, 2018, 2(5): 150-151. JIAO Ruishuang, WANG Guoxian, WANG Pin. Evaluation of the effect of ultrasound-guided puncture intervention on ovarian function and efficacy in patients with ovarian cysts [J]. Journal of Imaging Research and Medical Applications, 2018, 2(5): 150-151.
[15] Kim GH, Kim PH, Shin JH, et al. Ultrasound-guided sclerotherapy for the treatment of ovarian endometrioma: an updated systematic review and meta-analysis [J]. Eur Radiol, 2022, 32(3): 1726-1737.
[16] Crestani A, Merlot B, Dennis T, et al. Impact of laparoscopic sclerotherapy for ovarian endometriomas on ovarian reserve [J]. J Minim Invasive Gynecol, 2023, 30(1): 32-38.
[17] Garcia-Tejedor A, Martinez-Garcia JM, Candas B, et al. Ethanol sclerotherapy versus laparoscopic surgery for endometrioma treatment: a prospective, multicenter, cohort pilot study [J]. J Minim Invasive Gynecol, 2020, 27(5): 1133-1140.
[18] Lee JK, Ahn SH, Kim HI, et al. Therapeutic efficacy of catheter-directed ethanol sclerotherapy and its impact on ovarian reserve in patients with ovarian endometrioma at risk of decreased ovarian reserve: a preliminary study [J]. J Minim Invasive Gynecol, 2022, 29(2): 317-323.
[19] 景文达, 张宇晴, 黄瑛. 乙醇硬化治疗卵巢子宫内膜异位囊肿疗效的影响因素分析[J]. 中国临床医学影像杂志, 2022, 33(10): 724-728. JING Wenda, ZHANG Yuqing, HUANG Ying. Analysis of influencing factors on the efficacy of ethanol sclerotherapy for ovarian endometriotic cysts [J]. Journal of China Clinic Medical Imaging, 2022, 33(10): 724-728.
[20] 黄薇, 冷金花, 裴天骄, 等. 子宫内膜异位症患者生育力保护的中国专家共识(2022版)[J]. 中华妇产科杂志, 2022, 57(10): 733-739. HUANG Wei, LENG Jinhua, PEI Tianjiao, et al. Fertility protection and preservation for patients with endometriosis: a Chinese consensus(2022)[J]. Chinese Journal of Obstetrics and Gynecology, 2022, 57(10): 733-739.
[21] 周应芳. 子宫内膜异位症患者长期管理的必要性[J]. 中华妇产科杂志, 2017, 52(3): 145-146. ZHOU Yingfang. The necessity of long-term management of patients with endometriosis [J]. Chinese Journal of Obstetrics and Gynecology, 2017, 52(3): 145-146.
[22] 黄婷, 黄高廷, 杨国敏, 等. 地诺孕素用于子宫内膜异位症保守术后维持治疗的Meta分析[J]. 国际妇产科学杂志, 2021, 48(1): 26-34. HUANG Ting, HUANG Gaoting, YANG Guomin, et al. Meta analysis of dienogest used in maintenance treatment of endometriosis after conservative surgery [J]. Journal Of International Obstetrics and Gynecology, 2021, 48(1): 26-34.
[23] Muzii L, Galati G, Di Tucci C, et al. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain [J]. Gynecol Endocrinol, 2020, 36(1): 81-83.
[24] Romer T. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice [J]. Arch Gynecol Obstet, 2018, 298(4): 747-753.
[25] Chen T, Wei JL, Leng T, et al. The diagnostic value of the combination of hemoglobin, ca199, ca125, and he4 in endometriosis [J]. J Clin Lab Anal, 2021, 35(9): e23947. doi: 10.1002/jcla.23947.
[26] Yoshino O, Minamisaka T, Ono Y, et al. Three cases of clear-cell adenocarcinoma arising from endometrioma during hormonal treatments [J]. J Obstet Gynaecol Res, 2018, 44(9): 1850-1858.

相关文章 15

[1]	王兴山,张浩天,张云峰,周一新. 旋转铰链膝在复杂初次膝关节置换中的应用及临床疗效[J]. 山东大学学报 (医学版), 2026, 64(4): 51-57.
[2]	罗淇,王霞,姜孟. 脑功能网络分析在失语症诊疗中的应用:病理机制分析、临床诊断与疗效评价[J]. 山东大学学报 (医学版), 2025, 63(8): 111-126.
[3]	苗壮,刘培来. 双柱活动平台单髁假体治疗膝关节前内侧骨关节炎的中期疗效[J]. 山东大学学报 (医学版), 2025, 63(7): 62-67.
[4]	国科,陈绪军,郑宝石,施超,黄克力,曹勇,陈军,吴东凯,张晓慎,罗俊辉,申林,莫绪明,杨岷,王晓武,雷印胜,田茂州,王振东,孟自力,孙忠东,李有金,陆辉辉,孟春营,高峰,陈黔苏,郭能瑞,柳德斌,张楠,林宇,陈文生,宋保国,方智,王海晨,廖晓波,徐朝军. 快通道拔管在全动脉冠脉旁路移植术的多中心临床效果[J]. 山东大学学报 (医学版), 2025, 63(5): 26-32.
[5]	王建旭,彭晓辉,丰浩田,安森博,董恣豪,黄子帅,刘喆,杨光. 应用内支撑技术辅助膝关节前交叉韧带全内重建术近期疗效观察[J]. 山东大学学报 (医学版), 2025, 63(3): 22-27.
[6]	梁炎春,严莹,麦华希,姚书忠. 地诺孕素在子宫内膜异位症相关性疼痛中的治疗作用:从基础到临床[J]. 山东大学学报 (医学版), 2025, 63(10): 27-33.
[7]	贾振存,吴晨睿,赵德龙,朱可嘉,丁森泰. 八宝丹胶囊联合米拉贝隆治疗女性膀胱过度活动症的有效性与安全性[J]. 山东大学学报 (医学版), 2025, 63(10): 72-79.
[8]	孙晓丹,杨创. 多黏菌素B治疗ICU耐碳青霉烯类革兰阴性杆菌感染患者的效果[J]. 山东大学学报 (医学版), 2024, 62(7): 72-77.
[9]	冯绪强,高萍,孙超,陶琳,闫根全,冷冰. 替加环素治疗感染性疾病临床疗效及影响因素[J]. 山东大学学报 (医学版), 2024, 62(12): 11-20.
[10]	邵长秀,贺青卿,庄晓璇,周鹏,李小磊,岳涛,徐婧,李陈钰,郭浩男,庄大勇. 甲状旁腺全切加微量腺体自体移植术治疗109例肾性继发性甲状旁腺功能亢进的长期疗效[J]. 山东大学学报 (医学版), 2023, 61(4): 42-48.
[11]	杨晓斐,韩波,姜殿东,吕建利,伊迎春,张建军,赵立健,王静,王艳,袁辉. 经导管射频消融术治疗儿童快速性心律失常972例临床分析[J]. 山东大学学报 (医学版), 2023, 61(2): 49-56.
[12]	王成,张淑卉,闫娜,孟林林,陈良志,刘庆华. 脐带间充质干细胞治疗中晚期博来霉素诱导小鼠肺间质纤维化的机制[J]. 山东大学学报 (医学版), 2023, 61(10): 17-22.
[13]	巨艳丽,王丽华,成芳,黄凤艳,陈学禹,贾红英. 基于机器学习构建放射性碘治疗疗效的预测模型[J]. 山东大学学报 (医学版), 2023, 61(1): 94-99.
[14]	孙继业,王紫欧,孙晓伟,李洪涛. 中药熏蒸联合体外冲击波对72例髋关节撞击综合征临床疗效、血清炎症因子水平的影响[J]. 山东大学学报 (医学版), 2022, 60(4): 76-81.
[15]	李青,林雪艳,刘天航,李晓文,范明喆,赵瑞瑞,田永杰. 经阴道网片盆底重建术的疗效中长期随访[J]. 山东大学学报 (医学版), 2022, 60(3): 71-75.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed